SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients

Clinical trial NCT00608868 · COMPLETED

Trial details

NCT number: NCT00608868
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non Small Cell Lung Carcinoma

Start date: 2007-01-01
Primary completion: 2009-01-01
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.